Vitrolife AB (publ)
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more
Market Cap & Net Worth: Vitrolife AB (publ) (VTRLY)
Vitrolife AB (publ) (PINK:VTRLY) has a market capitalization of $2.44 Billion ($2.44 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #6349 globally and #3579 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vitrolife AB (publ)'s stock price $18.00 by its total outstanding shares 135447190 (135.45 Million).
Vitrolife AB (publ) Market Cap History: 2016 to 2025
Vitrolife AB (publ)'s market capitalization history from 2016 to 2025. Data shows growth from $1.65 Billion to $2.44 Billion (0.00% CAGR).
Vitrolife AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vitrolife AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.71x
Vitrolife AB (publ)'s market cap is 0.71 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.65 Billion | $856.11 Million | $190.37 Million | 1.92x | 8.65x |
| 2017 | $2.11 Billion | $1.05 Billion | $263.64 Million | 2.02x | 8.01x |
| 2018 | $2.15 Billion | $1.15 Billion | $309.70 Million | 1.87x | 6.94x |
| 2019 | $2.18 Billion | $1.48 Billion | $382.79 Million | 1.47x | 5.70x |
| 2020 | $3.44 Billion | $1.25 Billion | $286.85 Million | 2.77x | 12.01x |
| 2021 | $7.98 Billion | $1.68 Billion | $341.00 Million | 4.74x | 23.39x |
| 2022 | $2.61 Billion | $3.23 Billion | $394.00 Million | 0.81x | 6.62x |
| 2023 | $1.80 Billion | $3.51 Billion | -$3.85 Billion | 0.51x | N/A |
| 2024 | $2.59 Billion | $3.61 Billion | $513.00 Million | 0.72x | 5.04x |
| 2025 | $2.44 Billion | $3.44 Billion | -$4.71 Billion | 0.71x | N/A |
Competitor Companies of VTRLY by Market Capitalization
Companies near Vitrolife AB (publ) in the global market cap rankings as of March 18, 2026.
Key companies related to Vitrolife AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Vitrolife AB (publ) Historical Marketcap From 2016 to 2025
Between 2016 and today, Vitrolife AB (publ)'s market cap moved from $1.65 Billion to $ 2.44 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.44 Billion | -5.76% |
| 2024 | $2.59 Billion | +43.61% |
| 2023 | $1.80 Billion | -30.97% |
| 2022 | $2.61 Billion | -67.28% |
| 2021 | $7.98 Billion | +131.52% |
| 2020 | $3.44 Billion | +57.93% |
| 2019 | $2.18 Billion | +1.47% |
| 2018 | $2.15 Billion | +1.76% |
| 2017 | $2.11 Billion | +28.27% |
| 2016 | $1.65 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Vitrolife AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.44 Billion USD |
| MoneyControl | $2.44 Billion USD |
| MarketWatch | $2.44 Billion USD |
| marketcap.company | $2.44 Billion USD |
| Reuters | $2.44 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.